Skip to content
Menu

Pulse Biosciences, Inc. PLSE

Full chart Compare
Set alert

Price alert · PLSE

All alert types
45.55 USD +1.14 (+2.57%)

Regular-session close

45.50 -0.05 -0.11%

After hours · Nov 20, 4:54 PM ET

43.84 Day range 46.00
12.70 52-week range 58.94
YTD
+231.76%
1 year
+259.79%

5D -4.01 (-8.03%)

4547.5050MonTueWedThuFri45.93
Market cap
3.35B
Revenue (ttm)
1.49M
EPS (ttm)
-1.21
Shares out
73.55M
Forward P/E
-39.35
YTD return
+231.76%
1-year return
+259.79%
50-day average
51.30
200-day average
33.97
Enterprise value
3.08B
Volume
466.85K
Avg volume
503.30K
Open
44.01
Previous close
44.41
Day's range
43.84 – 46.00
52-week range
12.70 – 58.94
Beta
1.64
Analysts
Strong Buy
Price target
67.67 (+48.6%)
Earnings date
Feb 18, 2027

Key statistics

Price / sales
2242.41
Price / book
18.19
Revenue growth
359.30%
Free cash flow
-34.23M
Total cash
189.19M
Total debt
6.36M
Return on equity
-60.61%
Short % of float
12.44%

Fundamental scorecard

5 of 25 checks passed on PLSE’s reported financials

ValueGrowthProfitabilityHealthDividend

5of 25 checks passed

  • Value 0 of 5
  • Growth 1 of 5
  • Profitability 1 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
PLSE Revenue — quarterly 395.00K
PLSE Net income — quarterly -23.05M
PLSE EPS — quarterly -0.32

Earnings

PLSE recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 18, 2027Dec 30, 2026-0.33———
Nov 5, 2026Sep 30, 2026-0.3095-0.32-0.01-3.39%
Aug 6, 2026Jun 30, 2026-0.31-0.36-0.05-16.13%
May 4, 2026Mar 31, 2026-0.32-0.27+0.05+15.62%
Feb 19, 2026Dec 31, 2025-0.265-0.26+0.01+1.89%
Nov 5, 2025Sep 30, 2025-0.31-0.29+0.02+6.45%

Upgrades / downgrades

PLSE analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026Canaccord GenuitymainBuyBuy
Nov 6, 2026NeedhammainBuyBuy
Oct 13, 2026OppenheimermainOutperformOutperform
Oct 6, 2026Canaccord GenuitymainBuyBuy
Sep 23, 2026BTIGinit—Buy
Sep 9, 2026Freedom Capital Marketsinit—Buy

About Pulse Biosciences, Inc.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on PLSE — it syncs with the Stock Master app.

Insider holders

PLSE insider holders
InsiderRelationLatest transactionDateShares held
BARRETT BURKE TFormerSaleDec 10, 202463,172
DANAHY KEVIN PATRICKOfficerConversion of Exercise of derivative securityFeb 17, 202643,298
DUGGAN ROBERT WILLIAMDirector and Beneficial Owner of more than 10% of a Class of SecurityPurchaseMay 10, 202649,291,700
LAVIOLETTE PAUL AChief Executive OfficerPurchaseMay 10, 202615,846
UECKER DARRIN RChief Technology OfficerConversion of Exercise of derivative securitySep 16, 2025284,406
ZANGANEH MAHKAMDirectorConversion of Exercise of derivative securityFeb 2, 2025873,469

Institution ownership

PLSE institution ownership
Holder% heldSharesValueReported
Price (T.Rowe) Associates Inc3.79%2,789,996127.08MSep 29, 2026
Blackrock Inc.2.28%1,673,89676.25MSep 29, 2026
Citadel Advisors Llc2.02%1,484,41667.62MSep 29, 2026
Bank of America Corporation1.99%1,467,17866.83MSep 29, 2026
Vanguard Capital Management LLC1.28%937,95042.72MSep 29, 2026
Balyasny Asset Management LP0.86%631,66928.77MSep 29, 2026

Fund ownership

PLSE fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund0.75%554,61225.26MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF0.67%489,64322.30MSep 29, 2026
T. Rowe Price New Horizons Fund, Inc.0.66%485,30022.11MJun 29, 2026
MFS SERIES TRUST I-MFS New Discovery Fund0.46%339,45315.46MAug 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.29%215,8809.83MJun 29, 2026
TR PRICE-Price (T.Rowe) New Horizons Trust0.29%214,4009.77MJun 29, 2026